Amphastar Pharmaceuticals Inc (AMPH)

Apr 21, 2025

BofA Adjusts Price Target on Amphastar Pharmaceuticals to $31 From $36 - marketscreener.com

Apr 21, 2025

Apr 21, 2025

U.S. Naloxone Market Is Booming So Rapidly 2025-2032 -Amphastar Pharmaceuticals Inc., Emergent BioSolutions Inc - openPR.com

Apr 21, 2025

Apr 21, 2025

JPMorgan Chase & Co. Sells 385,349 Shares of Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) - MarketBeat

Apr 21, 2025

Apr 20, 2025

Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) Shares Sold by LSV Asset Management - MarketBeat

Apr 20, 2025

Apr 18, 2025

Renaissance Technologies LLC Acquires 36,100 Shares of Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) - MarketBeat

Apr 18, 2025

Apr 18, 2025

Amphastar Pharmaceuticals (NASDAQ:AMPH) Sets New 1-Year LowShould You Sell? - MarketBeat

Apr 18, 2025

Apr 18, 2025

Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) Shares Bought by Alliancebernstein L.P. - Defense World

Apr 18, 2025

Apr 17, 2025

Geode Capital Management LLC Lowers Position in Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) - Defense World

Apr 17, 2025

Apr 16, 2025

Amphastar stock hits 52-week low at $22.73 amid market challenges By Investing.com - Investing.com South Africa

Apr 16, 2025

Apr 16, 2025

Bessemer Group Inc. Buys 11,609 Shares of Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) - MarketBeat

Apr 16, 2025

Apr 16, 2025

Amphastar stock hits 52-week low at $22.73 amid market challenges - Investing.com Australia

Apr 16, 2025

Apr 16, 2025

Portolan Capital Management LLC Cuts Stock Position in Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) - MarketBeat

Apr 16, 2025

Apr 16, 2025

Franklin Resources Inc. Sells 1,060 Shares of Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) - Defense World

Apr 16, 2025

Apr 15, 2025

Is Amphastar Pharmaceuticals, Inc. (AMPH) the Best Pharma Stock to Buy for Long Term Growth? - Insider Monkey

Apr 15, 2025

Apr 15, 2025

2 Reasons to Like AMPH and 1 to Stay Skeptical - Yahoo Finance

Apr 15, 2025

Apr 15, 2025

Amphastar Pharmaceuticals' (AMPH) "Hold" Rating Reaffirmed at Needham & Company LLC - MarketBeat

Apr 15, 2025

Apr 15, 2025

Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) Shares Sold by Wellington Management Group LLP - Defense World

Apr 15, 2025

Apr 15, 2025

Hyaluronidase Market Growth, Trends & Insights 2024-2031 | Top - openPR.com

Apr 15, 2025

Apr 14, 2025

Federated Hermes Inc. Lowers Stock Holdings in Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) - MarketBeat

Apr 14, 2025

Apr 14, 2025

Renaissance Group LLC Has $3.70 Million Position in Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) - MarketBeat

Apr 14, 2025

Apr 12, 2025

Amphastar Pharmaceuticals (NASDAQ:AMPH) Sets New 12-Month LowShould You Sell? - MarketBeat

Apr 12, 2025

Apr 12, 2025

Needham & Company LLC Reiterates Hold Rating for Amphastar Pharmaceuticals (NASDAQ:AMPH) - Defense World

Apr 12, 2025

Apr 11, 2025

Amphastar Pharmaceuticals, Inc.'s (NASDAQ:AMPH) Stock Has Been Sliding But Fundamentals Look Strong: Is The Market Wrong? - Yahoo Finance

Apr 11, 2025

Apr 11, 2025

Dynamic Technology Lab Private Ltd Acquires 14,468 Shares of Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) - MarketBeat

Apr 11, 2025

Apr 10, 2025

Glucagon Market Set to Witness Significant Growth by 2032 | Eli - openPR.com

Apr 10, 2025

Apr 10, 2025

Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) Stock Position Increased by Vanguard Group Inc. - Defense World

Apr 10, 2025

Apr 10, 2025

Trexquant Investment LP Buys 16,248 Shares of Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) - MarketBeat

Apr 10, 2025

Apr 09, 2025

Amphastar at Needham Conference: Strategic Growth Amidst Challenges By Investing.com - Investing.com Canada

Apr 09, 2025

Apr 07, 2025

Amphastar stock hits 52-week low at $25.72 amid market challenges - Investing.com Australia

Apr 07, 2025

Apr 07, 2025

Amphastar stock hits 52-week low at $25.72 amid market challenges By Investing.com - Investing.com South Africa

Apr 07, 2025

Apr 07, 2025

Insider Selling: Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) Director Sells 500 Shares of Stock - MarketBeat

Apr 07, 2025

Apr 07, 2025

Corebridge Financial Inc. Sells 1,613 Shares of Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) - Defense World

Apr 07, 2025

Apr 06, 2025

Amphastar Pharmaceuticals (NASDAQ:AMPH) Trading Down 3.1%Should You Sell? - MarketBeat

Apr 06, 2025

Apr 05, 2025

Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) Shares Sold by American Century Companies Inc. - MarketBeat

Apr 05, 2025

Apr 04, 2025

Amphastar Pharmaceuticals to Release Second Quarter Earnings and Hold Conference Call on August 9th, 2021 - ACCESS Newswire

Apr 04, 2025

Apr 04, 2025

We Think Amphastar Pharmaceuticals (NASDAQ:AMPH) Can Stay On Top Of Its Debt - simplywall.st

Apr 04, 2025

Apr 03, 2025

Amphastar Pharmaceuticals to Release Second Quarter Earnings and Hold Conference Call on August 8, 2023 - ACCESS Newswire

Apr 03, 2025

Apr 03, 2025

Amphastar Pharmaceuticals to Present at the 24th Annual Needham Virtual Healthcare Conference - ACCESS Newswire

Apr 03, 2025

Apr 03, 2025

Amphastar Leadership Team Set for Major Investor Presentation at Needham Conference - Stock Titan

Apr 03, 2025

Apr 02, 2025

Amphastar Pharmaceuticals director sells $14,190 in stock - Investing.com India

Apr 02, 2025

Apr 02, 2025

Amphastar Pharmaceuticals director sells $14,190 in stock By Investing.com - Investing.com South Africa

Apr 02, 2025

Apr 02, 2025

Amphastar Pharmaceuticals to Release Fourth Quarter Earnings and Hold Conference Call on March 10th, 2022 - ACCESS Newswire

Apr 02, 2025